At MMC Laboratories, we are driving innovation in the pharmaceutical cannabis sector by delivering high-quality, cannabis-derived active pharmaceutical ingredients (APIs) for the global market.

Founded in September 2022 and based in Lilongwe, Malawi, MMC Laboratories was established in response to the rising international demand for reliable, medically beneficial cannabis products. Backed by an experienced leadership team in the cannabis and pharmaceutical industries, we are committed to being the trusted partner in the production of quality cannabis APIs.